NORTH AMERICA SYNTHETIC OPIOIDS MARKET ANALYSIS
North America Synthetic Opioids Market: Key Developments
Key market players are focused on receiving approvals for their opioids product by regulatory bodies, and this is expected to drive the North America synthetic opioids market growth over the forecast period. For instance, in May 2021, Amphastar Pharmaceuticals, Inc., a pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved its Morphine Sulfate injection 1mg/mL in the 30mL Pump-Jet Prefilled Syringe System. It is recommended for the use of patient-controlled analgesia (PCA) to treat pain that is severe enough to call for the use of an opioid analgesic.
North America Synthetic Opioids Market: Key Trends
Increasing Product Launch By Key Market Players
Key market players are focusing on launching new product, and this is expected to drive the North America synthetic opioids market growth over the forecast period. For instance, in May 2020, Hikma Pharmaceuticals PLC, a pharmaceutical company, launched Buprenorphine Hydrochloride Injection, 0.3mg/mL, the generic version of Buprenex in the U.S. Buprenorphine HCl Injection is used to treat pain that is severe enough to need an opioid analgesic and for which other treatments are ineffective.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
